IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, T.
Right arrow Articles by Chakrabarty, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, T.
Right arrow Articles by Chakrabarty, A. M.

 Previous Article  |  Next Article 

Infection and Immunity, December 2002, p. 7054-7062, Vol. 70, No. 12
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.12.7054-7062.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

The Bacterial Redox Protein Azurin Induces Apoptosis in J774 Macrophages through Complex Formation and Stabilization of the Tumor Suppressor Protein p53

Tohru Yamada,1 Masatoshi Goto,1 Vasu Punj,1 Olga Zaborina,1,{dagger} Kazuhide Kimbara,1,{ddagger} T. K. Das Gupta,2 and A. M. Chakrabarty1*

Department of Microbiology & Immunology,1 Department of Surgical Oncology, University of Illinois College of Medicine, Chicago, Illinois 606122

Received 23 May 2002/ Returned for modification 29 August 2002/ Accepted 6 September 2002


   ABSTRACT
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
Two redox proteins, azurin and cytochrome c551 elaborated by Pseudomonas aeruginosa, demonstrate significant cytotoxic activity towards macrophages. Azurin can enter macrophages, localize in the cytosol and nuclear fractions, and induce apoptosis. Two redox-negative mutants of azurin have less cytotoxicity than does wild-type (wt) azurin. Azurin has been shown to form a complex with the tumor suppressor protein p53, a known inducer of apoptosis, thereby stabilizing it and enhancing its intracellular level. A higher level of reactive oxygen species (ROS), generated during treatment of macrophages with wt azurin, correlates with its cytotoxicity. Treatment with some ROS-removing antioxidants greatly reduces azurin-mediated cytotoxicity, thus demonstrating a novel virulence property of this bacterial redox protein.


   INTRODUCTION
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Bacterial pathogens such as Pseudomonas aeruginosa (35) and many others (4, 29) produce a range of virulence factors that allow the bacteria to escape host defense and cause disease. Some of these virulence factors induce apoptosis in phagocytic cells such as macrophages to subvert the host defense (22, 45). Very little information is available, however, about the role of any purified bacterial virulence factor in triggering apoptosis in mammalian cells. An important inducer of mammalian cell apoptosis is the tumor suppressor protein p53 (2, 31, 40). A model for p53-induced apoptosis envisaged three critical steps: (i) the transcriptional induction of redox-related genes; (ii) the formation of reactive oxygen species (ROS); and (iii) the oxidative degradation of mitochondrial components, culminating in cell death (26). The release of cytochrome c from the mitochondria, resulting in complex formation with Apaf-1 and the activation of caspases such as caspase 9 (1), is a critical process in mammalian cell apoptosis, and p53-mediated apoptosis is known to involve caspase cascade activation (30, 31, 33). However, the level of p53 is quite low in normal mammalian cells due to its short half-life of a few minutes, primarily due to its degradation through the ubiquitin proteasome pathway (19). Stabilization and consequent higher levels of intracellular p53 can be achieved either through DNA-damaging agents such as UV radiation, which inhibits p53 ubiquitination (18), or through complex formation with specific proteins such as simian virus 40 T antigen (37) or with mammalian redox proteins such as NADH quinone oxidoreductase 1 (NQO1), which may act through accumulation of intracellular NAD+ (3).

In addition to stabilization of p53 by NQO1, which inhibits its degradation (3), redox proteins may contribute to the activation of p53 by stimulating its DNA-binding activity as a transcriptional activator. For example, the oxidized form of p53, which is inactive for DNA binding, is greatly stimulated in its DNA-binding activity in the presence of a dual-function redox and repair protein, Ref-1, particularly in the presence of reducing agents (13). Since p53 transcriptionally regulates the level of proapoptotic proteins such as Bax, NOXA, and P53AIP1 (25, 28), mammalian redox proteins such as Ref-1 play an important role in p53-mediated induction of apoptosis by enhancing the transcription of proapoptotic genes in mammalian cells (8).

Redox proteins such as azurin and cytochrome c551 are involved in electron transfer during denitrification in P. aeruginosa (38). A great deal is known about the structure of these proteins, and many site-directed mutants are available (6, 7,39). Azurin is a type I blue copper protein with a molecular mass of 14 kDa, while cytochrome c551 (9 kDa) is a haem-containing cytochrome. Azurin possesses a relatively large hydrophobic patch close to the active site, and two residues in this hydrophobic patch, Met-44 and Met-64, are believed to be involved in its interaction with the redox partners cytochrome c551 and nitrite reductase (39). Similarly, amino acid residues such as His-46 and His-117 are important for electron transfer, since the site-directed mutants His-46Gly (H46G) and His-117Gly have only 34 and 15% of the activity of the wild-type azurin (7). The double mutant Met-44Lys/Met-64Glu (M44K/M64E) is deficient in binding to its redox partners and demonstrates 3.4 and 3.3% of the electron transfer activity of wild-type azurin towards cytochrome c551 and nitrite reductase, respectively (7). Although a great deal is known about these two redox proteins with regard to their electron transfer activity, nothing is known about any cytotoxicity of these two proteins towards phagocytic or other mammalian cells. In this article, we demonstrate that purified azurin and cytochrome c551 from P. aeruginosa exhibit cytotoxicity towards macrophages. We additionally demonstrate that azurin forms a complex with the tumor suppressor protein p53, generates reactive oxygen species (ROS), and induces apoptosis in macrophages. That the cytotoxicity is due to azurin and not due to contaminating cellular constituents such as cell wall lipopolysaccharides is clear from their absence in the purified wild-type or mutant azurin preparations and from the fact that several mutant azurins isolated by the same purification procedure as the wild type demonstrated very low cytotoxicity, even though they might have been contaminated by the same cellular constituents present in the wild type.


   MATERIALS AND METHODS
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Bacteria and growth media. Escherichia coli JM109 was used as a host strain for expression of the azurin-encoding gene (azuA) of P. aeruginosa strain PAO1. The recombinant E. coli strain was cultivated in 2YT medium containing 50 µg of ampicilin/ml, 0.1 mM IPTG, and 0.5 mM CuSO4 for 16 h at 37°C to produce azurin. E. coli JCB7120 was used as a host strain for expression of the cytochrome c551-encoding gene of P. aeruginosa. The recombinant strain JCB7120 was cultivated under anaerobic condition at 37°C in the minimal medium as described previously (12).

Purification of wild-type and mutant azurins. azuA was amplified by PCR according to the method described by Kukimoto et al. (15). For expression of the P. aeruginosa cytochrome c551 gene, a plasmid, pkk223-3-PAC551, was used as described by Hasegawa et al. (10). Periplasmic fractions including azurin and cytochrome c551 from recombinant E. coli strains were obtained according to the method described by Cornelis et al. (5). Recombinant E. coli cells harvested from 5-liter cultures were washed with 1.2 liter of 10 mM Tris-HCl, pH 8.0, and centrifuged. The resultant cell pellets were suspended in 400 ml of 25% sucrose solution containing 0.1 mM EDTA and were shaken at room temperature for 15 min prior to centrifugation. The resultant cell pellets were suspended in 400 ml of ice-cold water and shaken again for 15 min prior to centrifugation. This supernatant was used as the periplasmic fraction. A mixture of 1 M Tris-HCl, pH 8.0, 1 M CuSO4, and 0.1 M potassium ferricyanide was then added to the periplasmic fraction containing azurin to adjust their final concentrations to 10, 1, and 0.1 mM, respectively. The fraction was mixed with a Q-Sepharose Fast Flow resin that had previously been equilibrated with 10 mM Tris-HCl, pH 8.0. The flowthrough fraction unbound to the Q-Sepharose gel was concentrated by Amicon YM-10. Purified azurin was obtained after gel filtration using a Hiprep 16/60 Superdex 75 column. The periplasmic fraction containing cytochrome c551 in 10 mM Tris-HCl, pH 8.0, was concentrated by Centriprep YM-3. The fraction was applied to a MonoQ column equilibrated with 10 mM Tris-HCl, pH 8.0. Proteins were eluted using a linear gradient from 0 to 0.15 M NaCl in 10 mM Tris-HCl, pH 8.0. The fraction showing redness was eluted with 0.05 M NaCl. This fraction was applied to a Superdex 75 column as described for azurin, and the red fraction was obtained as purified cytochrome c551.

Macrophage culture and cytotoxicity assay. The J774 cell-line-derived murine macrophage cells were cultured in RPMI 1640 medium containing L-glutamine, buffered with 10 mM HEPES, and supplemented with 10% fetal bovine serum, 100 U of penicillin/ml, and 100 µg of streptomycin/ml at 37°C in a humidified incubator with 5% CO2. For measurement of the cytotoxic activity of azurin or cytochrome c551, the 3-(4,5-dimethylthiazol-2-yl-2,5-diphenyl tetrazolium bromide) (MTT) assay (23) was conducted as described previously (14). Then 105 cells of the macrophages per well were seeded onto 96-well culture plates in 200 µl of RPMI 1640 medium. After overnight culture, the cells were washed with the same medium and were then replaced with fresh medium containing azurin. After 24 h treatment, 10 µl of 5-mg/ml MTT solution was added to the culture and incubated for 2.5 h at 37°C. The MTT reaction was terminated by the addition of 40 mM HCl in isopropanol. The MTT formazan formed was measured spectrophotometrically as described earlier (23).

Measurement of apoptotic cells. To determine the extent of cytotoxicity due to induction of apoptosis, 1.5 x 106 cells were seeded per well into six-well culture plates in 3 ml of RPMI 1640 medium. After overnight culture, the cells were washed with the same media and then were replaced with 2 ml of new media containing 20 µg of wild-type azurin or the mutant proteins per ml. After 16 h of treatment, flow cytometry analysis (Becton Dickinson) with the ApoAlert mitochondrial membrane sensor kit (Clontech) was used to determine the extent of apoptotic cells.

Preparation of macrophage cytosolic extracts for caspase assays. The macrophage cytosolic extracts were prepared as described by Zaborina et al. (43). Briefly, 20 ml of macrophage culture medium in a culture bottle was removed. Ten milliliters of ice-cold phosphate-buffered saline (PBS) (pH 7.2) was added, and adhered cells were lifted gently off the bottle. The cytosolic extract was then prepared as described previously (43). Caspase 9 and caspase 3 assays in the macrophage cytosolic extracts were conducted as previously described (43), using N-acetyl-Leu-Glu-His-Asp-p-NO2-aniline and N-acetyl-Asp-Glu-Val-Asp-p-NO2-aniline as substrates as described in the Fig. 2 legend.



View larger version (50K):
[in this window]
[in a new window]
  		FIG. 2. Measurement of caspase activities in the cytosolic extracts of macrophages treated with or without azurin and cytochrome c551 (50 and 25 µg/ml, respectively). (A) Determination of caspase 3 activity involved N-acetyl-Asp-Glu-Val-Asp-p-NO2-aniline as a substrate. Release of p-NO2-aniline was measured spectrophotometrically at 405 nm from the caspase 3 substrate (200 µM) with or without the inhibitor N-acetyl-Asp-Glu-Val-Asp-CHO (Ac-DEVD-CHO) (used at 0.05 molar ratio [inhibitor/substrate ratio]) after various periods of incubation at 37°C with macrophage cytosolic extract. Fifty micrograms of macrophage cytosolic extract protein was used in each case. (B) Caspase 9 activity determination involved release of p-NO2-aniline from 200 µM N-acetyl-Leu-Glu-His-Asp-p-NO2-aniline as a substrate after various periods of incubation with cytosolic extract of buffer-incubated macrophages (untreated) or cytosolic extract of macrophages incubated overnight with 50 and 25 µg, respectively, of azurin and cytochrome c551/ml (treated); the same extract from treated macrophages was also incubated with the substrate in the presence of the caspase 9 inhibitor, N-acetyl-Leu-Glu-His-Asp-CHO (Ac-LEHD-CHO). Fifty micrograms of macrophage cytosolic extract protein was used in all experiments. The TUNEL assay (C) was used for detection of apoptosis-induced nuclear DNA fragmentation using the ApoAlert DNA fragmentation assay kit (Clontech). J774 cell-line-derived macrophages were grown on Lab Tek chamber slides and incubated for 2, 6, and 12 h with azurin and cytochrome c551 (50 and 25 µg/ml). A negative control (untreated) without treatment (with buffer for 12 h) was also maintained. Macrophages viewed under both red and green channels as well as superimposed images are shown.

 
Detection of DNA fragmentation by TUNEL assay. For the terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assay, the ApoAlert DNA fragmentation assay kit (Clontech) was used; the assay was performed as recommended by the manufacturer. Briefly, macrophages were seeded at a density of 105 cells on Lab Tex chamber slides for 2 h. The macrophages were then treated with azurin and cytochrome C551 (50 and 25 µg/ml) for different time intervals. Simultaneously, cells were treated with PBS (untreated) as a negative control. The cells were washed and fixed in 4% paraformaldehyde-PBS and permeabilized with prechilled 0.2% Triton X-100-PBS for 5 min on ice. The slides were washed with PBS and equilibrated with equilibration buffer. The tailing reaction was performed using the ApoAlert DNA fragmentation assay kit. Fifty microliters of equilibration buffer, 5 µl of nucleotide mixture containing fluorescein-dUTP, and 0.5 µl of terminal deoxynucleotidyltransferase enzyme were evenly spread on the treated area and incubated in a humid chamber at 37°C for 1 h. The reaction was terminated by incubating the slides with 2x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate) for 15 min at room temperature. The cells were then stained with 1 µg of propidium iodide per ml and washed. A drop of antifade solution (Vectashield; Vecter Co.) was added, and the treated portion of the slide was covered with a coverslip with the edges sealed with clear nail polish. Slides were viewed within 2 h under an LSM 510 confocal laser microscope equipped with a 40x objective using a dual-filter set for green fluorescence (488 nm) and red fluorescence (568 nm).

Gene array. To determine the gene expression profile of murine macrophages, the cells were incubated with 50 µg of azurin/ml and 25 µg of cytochrome c551/ml or without any treatment as a control for various periods (0, 3, 6, and 12 h). Total RNA from macrophages was isolated by the RNAqueous-Midi kit (Ambion). The mouse Apoptosis-1 GEArray kit (Super Array Inc., Bethesda, Md.) with 23 apoptosis-related genes, including the Bcl-2 family, caspase family, Fas, TRAIL, NF-{kappa}B, and p53, was used to measure the level of gene expression. Membranes and a [{alpha}-32P]cDNA probe were hybridized overnight. To compare the expressions of apoptotic genes in macrophage cells, signal intensity was measured by phosphorimager.

Subcellular fractionations of macrophages. Macrophages were treated with azurin (50 µg/ml) and cytochrome c551 (25 µg/ml) for 0, 3, 6, and 12 h. Mitochondria and cytosol fractions were prepared as described by Han et al. (9). After treatment, macrophages were suspended in buffer A (20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, and 1 mM dithiothreitol [DTT]) containing 250 mM sucrose and proteinase inhibitor cocktail (Sigma). The resultant suspension was passed five times through a 26-gauge needle. After centrifugation at 1,000 x g for 10 min, the supernatant was subjected to centrifugation at 10,000 x g for 20 min at 4°C to separate the mitochondrial pellet, which was resuspended in 10 mM Tris-acetate, pH 8.0-0.5% NP-40-5 mM CaCl2) buffer. For generating a cytosol fraction, the supernatant was centrifuged at 100,000 x g for 1 h. The nuclear extracts were prepared as described by Raffo et al. (27). Macrophages were lysed by homogenization in hypotonic cell lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, and protease inhibitor cocktail). The nuclei were separated by centrifugation and were resuspended in isotonic-glycerol nuclear lysis buffer (20 mM HEPES, pH 7.9, 25% glycerol, 420 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT, and protease inhibitors). Monoclonal antibodies raised against p53, Bax, and cytochrome c (Santa Cruz Biotechnology) were used for immunoblotting. Blots were also probed for actin by using monoclonal antiactin antibody (Sigma) and mitochondrial membrane protein cytochrome c oxidase subunit IV (COX IV) with monoclonal anti-COX IV antibody (Molecular Probes) for checking cross-contamination and as internal controls. Protein bands were visualized using enhanced chemiluminescence reagents (Amersham Corp.).

Microscopy. Azurin was conjugated with the fluorescent chemical Alexa Fluor 468 (Molecular Probes) and was incubated with macrophages for 30 min. Entry of fluorescent chemically labeled azurin into the macrophages was observed by confocal microscopy. Morphological changes of macrophages were seen by phase-contrast microscopy with a 40x objective.

Glycerol gradient centrifugation analysis. Complex formation between wild-type azurin, mutant azurin, and p53 was confirmed by glycerol gradient centrifugation analysis (24, 34, 42). Each purified protein, wild-type or mutant azurin, full-length glutathione S-transferase (GST)-p53, bovine serum albumin (BSA), or GST was used in 180-pmol amounts before loading. To allow complex formation, various combinations of proteins were incubated at 4°C overnight. The stepwise 5, 15, 20, 25, and 35% glycerol gradient was prepared as described by Shankar et al. (32). Sample proteins were mixed in a 5% glycerol solution (top layer). After centrifugation, fractions from each gradient were collected and tested by immunoblotting with antiazurin antibody and anti-p53 antibody.

Determination of p53 stability. To determine the stability of p53 in the presence of bacterial redox proteins, the macrophages were either treated with buffer (control) or treated with azurin (50 µg/ml) and cytochrome c551 (25 µg/ml) for 12 h. Cycloheximide (20 µg/ml) was then added to the culture media to prevent protein synthesis in the cells (18). p53 levels were measured in equal amounts of cell extract proteins by immunoblotting using a monoclonal anti-p53 antibody after various periods of cycloheximide addition. The intensity of bands at each time point after cycloheximide addition was measured densitometrically. The level of p53 was calculated at 0 to 6 h after cycloheximide addition. Because of the 12-h pretreatment of macrophages with azurin-cytochrome c551, the level of p53 at 0 h of cycloheximide addition is higher in the extracts of treated macrophages than that in the control; however, the levels are plotted as a percentage of the p53 level (with 0-h cycloheximide at 100%) in each case.

Flow cytometry analysis of ROS. For the detection of ROS in wild-type azurin- and mutant azurin (50 µg/ml each)-treated J774 cell-line-derived macrophages, 2', 7'-dichlorodihydrofluorescein-diacetate (DCHF-DA; Sigma) was used as a substrate (10 µM) by staining live cells for 30 min at 37°C and measuring the DCF (2',7'-dichlorofluorescein) green fluorescence by flow cytometry (16). Ten thousand cells were collected for flow cytometry analysis in each case. The protective effect of ROS-removing enzyme superoxide dismutase (SOD) or the vitamin E analogue Trolox (6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid; Sigma) on cytotoxicity was tested by incubating macrophages treated with 25 µg of azurin per ml in the absence or presence of various concentrations of these antioxidants. The MTT assay for cytotoxicity was conducted following 1-h preincubation with antioxidants and then exposure for 16 h to azurin and SOD or Trolox.


   RESULTS AND DISCUSSION
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
Azurin- and cytochrome c551-mediated cytotoxicity in macrophages. It was recently reported (43) that a column chromatographic (Q-Sepharose flowthrough) fraction enriched in azurin and cytochrome c551 from the growth medium of P. aeruginosa, as well as purified azurin and cytochrome c551 proteins (Sigma), demonstrated induction of apoptosis in macrophages. Murine peritoneal macrophages, J774 cell-line-derived macrophages, and primary peritoneal mast cells were all susceptible to azurin- and cytochrome c551-induced apoptosis (43). To gain a better understanding of the role of enzymatic redox activity or the mode of their action, we cloned the azurin and cytochrome c551 genes of P. aeruginosa PAO1 in the expression vector pUC19 in E. coli. Since the role of specific amino acid residues in the redox activity of azurin has been well delineated (7, 39), we also constructed two site-directed mutants, H46G for mutation in the active site and the double mutant M44K/M64E, for mutation in the hydrophobic patch, as described previously (7, 39). All the proteins produced a single band on a sodium dodecyl sulfate-polyacrylamide gel (Fig. 1A) and demonstrated greater than 95% purity. We then determined the cytotoxicity of the hyperproduced wild-type azurin and the two mutant proteins, as determined by the quantitative MTT assay (23). Purified wild-type azurin demonstrated significant cytotoxicity towards the macrophages, while the two redox-defective mutant proteins had much less activity (Fig. 1B). Cytochrome c551 demonstrated cytotoxicity towards macrophages but only at relatively high concentrations (Fig. 1C). Interestingly, a mixture of azurin and cytochrome c551 had a higher level of cytotoxicity (Fig. 1C). Treatment of macrophages with wild-type azurin produced cells with drastic morphological changes, including swelling, membrane blebbing, and vacuolization (Fig. 1D). Control untreated cells had no such effect, while mutant azurins produced fewer cells with abnormal morphology (Fig. 1D). Flow cytometry analysis using Mitosensor dye demonstrated that the mutant azurin proteins had less apoptosis-inducing activity (Fig. 1E), as noted earlier with the MTT assay (Fig. 1B).



View larger version (58K):
[in this window]
[in a new window]
  		FIG. 1. Cytotoxicity and apoptotic activity of azurin and cytochrome c551 toward J774 cell-line-derived macrophage cells. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of wild-type (wt) and mutant azurins (A). Mutant azurins and wild-type azurin, as well as cytochrome c551 of P. aeruginosa PAO1, were hyperproduced in E. coli. The cytotoxicity of wild-type and mutant azurin proteins and cytochrome (Cyt) c551 toward macrophages was determined by MTT assay (B and C). Percent cytotoxicity is expressed as percent macrophage cell death as compared to that of untreated control (0% cytotoxicity). Phase-contrast pictures of untreated or azurin-treated macrophages were taken with an inverted microscope (Nikon Diaphot 200) equipped with a 40x objective for checking the morphological changes (D). Arrowheads, morphological changes. The extent of cytotoxicity due to induction of apoptosis was determined by flow cytometry analysis (E). The relative cytotoxicity of M44K/M64E and H46G mutant azurins has been expressed as a percentage of that of the wild type, keeping the value of wild-type azurin as 100%.

 
Induction of apoptosis by azurin and cytochrome c551. To confirm that macrophage cell death, triggered by azurin and cytochrome c551, is indeed due to induction of apoptosis, we measured caspase 3 and caspase 9 activities (44) in macrophages, incubated overnight either with PBS (untreated) or with a mixture of 50 µg of azurin and 25 µg of cytochrome c551 per ml (treated). Extracts of such macrophages were then assayed for caspase 3 and caspase 9 activities. It is clear that the extracts of treated macrophages, but not those of untreated macrophages, showed high activity for caspase 3 (Fig. 2A) or caspase 9 (Fig. 2B). Such activity was very low, either in the absence of azurin-cytochrome c551 treatment of the macrophages or in the presence of the specific inhibitors N-acetyl-Asp-Glu-Val-Asp-CHO for caspase 3 and N-acetyl-Leu-Glu-His-Asp-CHO for caspase 9, suggesting that treatment of macrophages with azurin-cytochrome c551 led to significant activation of caspase 9 and caspase 3 activities, indicative of extensive apoptosis in such cells.

To determine a time course of the initiation of apoptotic activity when macrophages are subjected to azurin-cytochrome c551 treatment, we used the TUNEL assay to determine the extent of nuclear DNA fragmentation. The incorporation of fluorescein-conjugated dUTP in the fragmented nuclear DNA, leading to enhanced green fluorescence imparted by fluorescein and detected by confocal microscopy, demonstrated the initiation of apoptosis in macrophages at around 5 or 6 h and continuing beyond 12 h (Fig. 2C).

To determine if induction of apoptosis by azurin-cytochrome c551 might be due to transcriptional activation or repression of proapoptotic or antiapoptotic genes, we used DNA array chips harboring 23 such murine genes and determined the extent of expression of these genes as a function of azurin-cytochrome c551 treatment of murine macrophages for 3, 6, and 12 h. The data did not show significant (more than twofold) alteration in the expression of these genes following treatment with azurin-cytochrome c551.

Subcellular localization of azurin and the tumor suppressor protein p53. In order to see if the bacterial redox proteins may trigger apoptosis in nonphagocytic cells, we tried several mammalian cell lines, including p53-positive and p53-null cell lines. We noticed that p53-negative cell lines were resistant to undergoing apoptosis in the presence of azurin-cytochrome c551, while the p53-positive cell lines were more susceptible (42a). Since p53 is a known inducer of apoptosis (2, 31, 40), these observations indicated that p53 might play a role in the induction of apoptosis by azurin-cytochrome c551. To see if treatment with azurin-cytochrome c551 might alter the intracellular level of p53, we treated macrophages with azurin and cytochrome c551 (50 and 25 µg/ml, respectively) for 0, 3, 6, and 12 h and measured the level of p53 in the extracts of the treated (or untreated [0 h]) macrophages by Western blotting. We also measured the level of actin as an internal control (Fig. 3A and B). Significant elevation in the level of p53, but not of actin, was observed when the macrophages were treated with the redox proteins for 12 h (Fig. 3A and B).



View larger version (34K):
[in this window]
[in a new window]
  		FIG. 3. (A) Immunoblot analysis of p53 protein level in whole-cell extracts of macrophages untreated (0 h) or treated for 3, 6, and 12 h with azurin-cytochrome c551. (B) Subcellular fractionation of macrophage extracts treated as for panel A (B). p53, Bax, COX IV, actin, and cytochrome c protein levels were measured by immunoblotting in cytosolic (cytosol), mitochondrial (mito.), and nuclear fractions of macrophage cell extract. Fractionated samples were prepared as described in Materials and Methods. (C) Uptake of fluorescent chemical (Alexa Fluor 468)-labeled azurin in J774 cells was observed by confocal microscopy. (D) The localization of wild-type azurin in the subcellular fractions of macrophages either untreated (0 h) or treated with azurin for 3, 6, and 12 h was monitored by immunoblotting using antiazurin antibody (D).

 
To determine the subcellular localization of both azurin and p53 after treatment of macrophages with azurin-cytochrome c551, the macrophage cell extract was further fractionated to obtain cytosolic, mitochondrial, and nuclear fractions and the levels of p53 and azurin were determined in such fractions. p53 is a positive transcriptional activator of the bax gene (28) and induces apoptosis via the mitochondrial apoptosome cytochrome c release pathway (1, 33). Thus, we were also interested in knowing the levels of Bax in various subcellular fractions and the extent of release of cytochrome c from the mitochondria to the cytosol during treatment of the macrophages for 0, 3, 6, and 12 h with azurin-cytochrome c551. The level of p53 rose steadily in the cytosol and in the nuclear fractions during the 1-h period, but very little p53 was observed in the mitochondria (Fig. 3B). In contrast, the Bax level increased significantly in the mitochondria, particularly during 6 to 12 h when cellular apoptosis is initiated. The movement of Bax from cytosol to mitochondria during apoptosis of thymocytes, Cos-7 kidney epithelial cells, and L929 fibroblasts (11, 41) has been reported. There was a steady increase of cytochrome c in the cytosol during the 12-h period (Fig. 3B), suggesting a possible release of cytochrome c from the mitochondria to the cytosol. The COX IV subunit was detected only in the mitochondria and not in the cytosol, indicating that the cytosol was virtually free of the mitochondria. The actin was found in the cytosol but not in the nuclear fraction, suggesting that the nuclear fraction was significantly free of cytosolic contamination. Overall, azurin-cytochrome c551 treatment of the macrophages resulted in a steady accumulation of p53 in the cytosolic and nuclear fractions, while the Bax level increased mainly in the cytosolic and mitochondrial fractions. Significant release of mitochondrial cytochrome c to the cytosol occurred during 6 to 12 h of treatment.

To localize azurin during the treatment of macrophages with this protein, we used confocal microscopy of macrophages incubated for 30 min with chemically labeled (Alexa Fluor 468) green fluorescent azurin (Fig. 3C). Azurin was found to be located within the macrophage cell. Unlike azurin, another labeled protein, GST, did not show entry or intracellular accumulation (data not shown). We also examined various subcellular fractions for the presence of azurin by Western blotting using antiazurin antibody (Fig. 3D). Azurin was found to be localized in the cytosol and the nuclear fractions. The concentration of internalized azurin increased with an increasing period of incubation (Fig. 3D). No azurin was found in mitochondria. Since the redox-negative mutant azurin proteins had low cytotoxicity (Fig. 1B), it was of interest for us to see if this was due to lack of internalization of mutant azurins or a different subcellular localization. Incubation of the macrophages with the wild-type and mutant azurin proteins showed localization of both types of azurin in the nuclear fraction and in the cytosol (data not shown). This suggested that the low cytotoxicity of mutant azurin proteins is not due to a lack of entry into the macrophages.

Azurin forms a complex with p53 and stabilizes it. As previously mentioned, mammalian redox proteins such as NQO1 (3) and Ref-1 (8, 13) modulate p53 level or its activity by binding to it and preventing its degradation or enhancing its DNA-binding activity. We thus wanted to determine if the bacterial redox protein azurin or cytochrome c551 could form complexes with p53 and elevate its level by stabilizing it. Glycerol gradient centrifugation to study complex formation among sigma factor-anti-sigma factor (42) or other interacting proteins (24, 34) has previously been used. In this method, the proteins are sedimented by ultracentrifugation through a glycerol gradient, either singly or in combination. If the two proteins form a complex, then the complex sediments at a higher glycerol gradient than do the individual proteins. We used a 5 to 35% glycerol gradient to sediment wild-type azurin, p53 (a GST-p53 fusion protein was used), cytochrome c551, BSA, GST, and mutant azurin proteins H46G and the double mutant M44K/M64E either singly or in various combinations. The presence of azurin in various glycerol gradient fractions was then detected by collecting samples from these fractions and running Western blots using antiazurin or monoclonal anti-p53 (or anti-cytochrome c551) antibodies. Azurin by itself sedimented at 5% glycerol (Fig. 4A). When azurin and GST-p53 fusion protein were incubated before sedimentation, azurin could be detected at 5, 15, 20, and 25% glycerol fractions (Fig. 4A), suggesting the presence of a polydisperse complex. p53 is known to form aggregates (17) and was found to be present by itself in 5, 15, 20, and 25% glycerol gradient fractions as various aggregates (Fig. 4B). Incubation with azurin did not lead to its sedimentation at higher glycerol concentration, presumably because of the low molecular mass (14 kDa) of azurin. Azurin is known to associate with cytochrome c551 for its electron transfer reaction (38) and can be seen to form a polydisperse complex with cytochrome c551, similar to that with p53 (Fig. 4A). Other proteins such as BSA and GST, however, had no ability to form complexes with azurin (Fig. 4A), suggesting the specificity of azurin-p53 complex formation. The inability of GST to form a complex with azurin strongly suggests that the complex formation of azurin with GST-p53 fusion protein is due to p53 and not due to GST. Interestingly, the two mutant azurin proteins had much less affinity for complex formation with p53. It is not known if the reduced cytotoxicity of the mutant proteins might be due to reduced affinity for this complex formation, rather than to loss of their redox activity. Addition of the M44K/M64E mutant azurin to wild-type azurin had no significant effect on its cytotoxicity, indicating a lack of competition between the two.



View larger version (68K):
[in this window]
[in a new window]
  		FIG. 4. Complex formation and stabilization of p53 with azurin. Complex formation between wild-type azurin, mutant azurins, and p53 was confirmed by glycerol gradient centrifugation analysis using antiazurin (A) and anti-p53 (B) antibodies as described in Materials and Methods. The stability of p53 in the presence of bacterial redox proteins was measured by immunoblotting using anti-p53 antibody after 12 h of azurin treatment and subsequent addition of cycloheximide (C). The intensity of p53 bands was determined densitometrically and plotted with the 0-h value at 100% and by measuring p53 stability up to 6 h after cycloheximide addition (D) in untreated (control) and azurin-cytochrome c551 (Az/c551)-treated macrophages. Met-W, M44K/M64E.

 
To determine if complex formation of p53 with azurin-cytochrome c551 might stabilize p53, thus accounting for its higher intracellular level, we used the method described by Maki and Howley (18). We incubated macrophages either with buffer (untreated) or with azurin and cytochrome c551 (50 and 25 µg/ml) for 12 h, followed by the addition of 20 µg of cycloheximide per ml to prevent protein synthesis. The level of p53 in the macrophage extracts was then measured by Western blotting (Fig. 4C) using monoclonal anti-p53 antibody. The intensity of the bands was determined by using the enhanced chemiluminescence assay and was plotted as the percentage of p53 remaining of the initial cellular level at the time of addition of cycloheximide (0 h). The results (Fig. 4D) demonstrated that, while the level of p53 decreased steadily in untreated control cells in about 3 h, a substantial amount of p53 remained in the treated cells even after 6 h, suggesting its stabilization during azurin-cytochrome c551 treatment.

Correlation between cytotoxicity and ROS generation by azurin. Redox proteins such as PIG3 (26) and NQO1 (3) appear to be at least partly responsible for an increase in the formation of ROS in mitochondria, which has been implicated in the induction of apoptosis (21); however, ROS inhibitors have been reported to be unable to protect against p53-mediated apoptosis in some cases (31). On the other hand, antioxidants such as SOD have been shown to protect acute myeloblastic leukemia cells from undergoing apoptosis in the presence of the oxidative agent Etoposide (20). To see if the bacterial redox protein azurin might elicit a higher level of ROS formation in macrophages, we treated the macrophages either with buffer (untreated) or with 50 µg of wild-type azurin or mutant azurins H46G and M44K/M64E per ml. The level of ROS was then determined periodically for the next 24 h as DCF fluorescence generated from the substrated DCHF-DA (16). As opposed to buffer-treated macrophages, macrophages treated with wild-type azurin showed significant generation of ROS, while treatment with the mutant azurins generated a lower level of ROS, particularly during prolonged treatment (Fig. 5A). To see the effect of antioxidants such as catalase, SOD, and Trolox, a vitamin E analogue, on the azurin-induced cytotoxicity towards macrophage cells, macrophages were either not treated with azurin (0 µg/ml) or were treated with azurin at 25 µg/ml with or without concomitant addition of SOD at 0.1 and 1.0 kU/ml or Trolox at 0.1 and 1.0 mM (Fig. 5B). Similar experiments were done with catalase. While catalase had no effect on azurin-induced cytotoxicity, SOD at 1.0 kU/ml or Trolox at 1.0 mM significantly reduced the cytotoxicity exerted by 25 µg of azurin/ml (Fig. 5B), thus demonstrating a correlation between the level of Trolox- or SOD-susceptible ROS and azurin-induced cytotoxicity in macrophages. The redox-negative mutants generated lesser quantities of ROS and had less cytotoxicity, confirming the role of ROS, at least partly, in azurin-mediated induction of apoptosis in macrophages.



View larger version (18K):
[in this window]
[in a new window]
  		FIG. 5. ROS levels in live macrophage cells analyzed by flow cytometry (A). Macrophages were treated without (un-tr) or with wild-type (wt) or mutant azurins using DCHF-DA as a substrate, and the levels of ROS were measured as described in Materials and Methods (A). The extent of cytotoxicity in macrophage cells treated with or without azurins and/or antioxidants used at various concentrations as shown was determined by MTT assay (B). Met-W, M44K/M64E.

 
The ability of bacterial redox proteins such as azurin-cytochrome c551, which are secreted in the growth medium by pathogens such as P. aeruginosa (43) and which can be internalized in phagocytic cells such as macrophages, to allow complex formation and stabilization of tumor suppressor protein p53 and generation of enhanced level of ROS is an interesting example of how bacterial pathogens may subvert host defense through induction of host phagocytic cell apoptosis. Recent experiments indicate that some redox-negative mutant azurins can form complexes with p53, generate ROS, and induce macrophage apoptosis, suggesting that p53-mediated enhanced ROS generation is important for the induction of apoptosis. The role of mammalian redox proteins in the induction of p53-mediated apoptosis is a subject of considerable present interest (21). It remains to be seen if other microbial pathogens may elaborate similar redox proteins, either as virulence factors or as agents that facilitate microbial invasion and/or proliferation in eukaryotic organisms by complex formation with p53.

The enhanced cytosolic or mitochondrial Bax levels in murine macrophages during treatment with azurin-cytochrome c551 for prolonged periods (Fig. 3B) is most likely a reflection of high p53 levels in such cells. The reduced cytotoxicity of the two redox-negative mutant azurin proteins may similarly be correlated with their reduced ability to form complexes with p53 (Fig. 4A) and not to their loss of redox activity. The loss of the redox enzymatic functions in these two mutants, however, might also abolish their ability to activate p53-mediated binding to the response element of the bax genes (36) or to generate a significant amount of ROS. Further studies are under way to define clearly the role of enzymatic redox activity on azurin-mediated cytotoxicity and the ability of wild-type and redox-negative mutant azurins to modulate the DNA-binding activity of p53, as demonstrated for Ref-1 (8, 13).


   ACKNOWLEDGMENTS
 
This work was supported by Public Health Service grant ES-04050-17 from the National Institute of Environmental Health Sciences (NIEHS). M.G. is on a leave of absence from the Department of Biosciences and Biotechnology, Kyushu University, Fukuoka, Japan, and is supported by a fellowship from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan. T.Y. is a Visiting Scholar from the Department of Built Environment, Tokyo Institute of Technology, and K.K. is at the Environment Biotechnology Laboratory, Railway Technical Research Institute, Tokyo, Japan.

We thank Yasuo Igarashi of the University of Tokyo for the gift of the cytochrome c551 gene and J. A. Cole of the University of Birmingham, Birmingham, United Kingdom, for the gift of the E. coli strain JCB7120, where the cytochrome c551 gene was expressed.


   FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology & Immunology, University of Illinois College of Medicine, 835 S. Wolcott Ave., Chicago, IL 60612. Phone: (312) 996-4586. Fax: (312) 996-6415. E-mail: pseudomo{at}uic.edu. Back

Editor: J. T. Barbieri

{dagger} Present address: Department of Surgery, University of Chicago, Chicago, Ill. Back

{ddagger} Present address: Environmental Biotechnology Laboratory, Railway Technical Research Institute, Tokyo 185-8540, Japan. Back


   REFERENCES
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
1. Adrain, C., and S. J. Martin. 2001. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem. Sci. 26:390-397.[CrossRef][Medline]
2. Agarwal, M. L., W. R. Taylor, M. V. Chernov, O. B. Chernova, and G. R. Stark. 1998. The p53 network. J. Biol. Chem. 273:1-4.[Free Full Text]
3. Asher, G., J. Lotem, B. Cohen, L. Sachs, and Y. Shaul. 2001. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl. Acad. Sci. USA 98:1188-1193.[Abstract/Free Full Text]
4. Clark, V. L., and P. M. Bavoil. 1994. Methods in enzymology, vol. 235. Bacterial pathogenesis. Academic Press, Inc., San Diego, Calif.
5. Cornelis, P., C. Digneffe, and K. Willemot. 1982. Cloning and expression of a Bacillus coagulans amylase gene in Escherichia coli. Mol. Gen. Genet. 186:507-511.[CrossRef][Medline]
6. Cutruzzola, F., M. Arese, G. Ranghino, G. van Pouderoyen, G. Canters, and M. Brunori. 2002. Pseudomonas aeruginosa cytochrome c551: probing the role of the hydrophobic patch in electron transfer. J. Inorg. Biochem. 88:353-361.[CrossRef][Medline]
7. Farver, O., L. J. Jeuken, G. W. Canters, and I. Pecht. 2000. Role of ligand substitution on long-range electron transfer in azurins. Eur. J. Biochem. 267:3123-3129.[Medline]
8. Gaiddon, C., N. C. Moorthy, and C. Prives. 1999. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J. 18:5609-5621.[CrossRef][Medline]
9. Han, Z., K. Bhalla, P. Pantazis, E. A. Hendrickson, and J. H. Wyche. 1999. Cif (cytochrome c efflux-inducing factor) activity is regulated by Bcl-2 and caspases and correlates with the activation of Bid. Mol. Cell. Biol. 19:1381-1389.[Abstract/Free Full Text]
10. Hasegawa, J., H. Shimahara, M. Mizutani, S. Uchiyama, H. Arai, M. Ishii, Y. Kobayashi, S. J. Ferguson, Y. Sambongi, and Y. Igarashi. 1999. Stabilization of Pseudomonas aeruginosa cytochrome c(551) by systematic amino acid substitutions based on the structure of thermophilic Hydrogenobacter thermophilus cytochrome c(552). J. Biol. Chem. 274:37533-37537.[Abstract/Free Full Text]
11. Hsu, Y. T., K. G. Wolter, and R. J. Youle. 1997. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl. Acad. Sci. USA 94:3668-3672.[Abstract/Free Full Text]
12. Lobbi-Nivol, C., H. Crooke, L. Griffiths, J. Grove, H. Hussain, J. Pommier, V. Mejean, and J. A. Cole. 1994. A reassessment of the range of c-type cytochromes synthesized by Escherichia coli K-12. FEMS Microbiol. Lett. 119:89-94.[CrossRef][Medline]
13. Jayaraman, L., K. G. Murthy, C. Zhu, T. Curran, S. Xanthoudakis, and C. Prives. 1997. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 11:558-570.[Abstract/Free Full Text]
14. Korhonen, R., H. Kankaanranta, A. Lahti, M. Lahde, R. G. Knowles, and E. Moilanen. 2001. Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin. Biochem. J. 354:351-358.[CrossRef][Medline]
15. Kukimoto, M., M. Nishiyama, M. Tanokura, M. E. Murphy, E. T. Adman, and S. Horinouchi. 1996. Site-directed mutagenesis of azurin from Pseudomonas aeruginosa enhances the formation of an electron-transfer complex with a copper-containing nitrite reductase from Alcaligenes faecalis S-6. FEBS Lett. 394:87-90.[CrossRef][Medline]
16. Lotem, J., M. Peled-Kamar, Y. Groner, and L. Sachs. 1996. Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc. Natl. Acad. Sci. USA 93:9166-9171.[Abstract/Free Full Text]
17. Maki, C. G. 1999. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2. J. Biol. Chem. 274:16531-16535.[Abstract/Free Full Text]
18. Maki, C. G., and P. M. Howley. 1997. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell. Biol. 17:355-363.[Abstract]
19. Maki, C. G., J. M. Huibregtse, and P. M. Howley. 1996. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56:2649-2654.[Abstract/Free Full Text]
20. Mantymaa, P., T. Siitonen, T. Guttorm, M. Saily, V. Kinnula, E. R. Savolainen, and P. Koistinen. 2000. Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br. J. Haematol. 108:574-581.[CrossRef][Medline]
21. Meplan, C., M. J. Richard, and P. Hainaut. 2000. Redox signalling and transition metals in the control of the p53 pathway. Biochem. Pharmacol. 59:25-33.[CrossRef][Medline]
22. Monack, D. M., J. Mecsas, N. Ghori, and S. Falkow. 1997. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl. Acad. Sci. USA 94:10385-10390.[Abstract/Free Full Text]
23. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.[CrossRef][Medline]
24. Mukhopadhyay, S., S. Shankar, W. Walden, and A. M. Chakrabarty. 1997. Complex formation of the elongation factor Tu from Pseudomonas aeruginosa with nucleoside diphosphate kinase modulates ribosomal GTP synthesis and peptide chain elongation. J. Biol. Chem. 272:17815-17820.[Abstract/Free Full Text]
25. Oda, E., R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi, and N. Tanaka. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053-1058.[Abstract/Free Full Text]
26. Polyak, K., Y. Xia, J. L. Zweier, K. W. Kinzler, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389:300-305.[CrossRef][Medline]
27. Raffo, A. J., A. L. Kim, and R. L. Fine. 2000. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis. Oncogene 19:6216-6228.[CrossRef][Medline]
28. Reed, J. C. 1999. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17:2941-2953.[Abstract/Free Full Text]
29. Salyers, A. A., and D. D. Whitt. 1994. Bacterial pathogenesis: a molecular approach. ASM Press, Washington, D.C.
30. Schuler, M., E. Bossy-Wetzel, J. C. Goldstein, P. Fitzgerald, and D. R. Green. 2000. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J. Biol. Chem. 275:7337-7342.[Abstract/Free Full Text]
31. Schuler, M., and D. R. Green. 2001. Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 29:684-688.[CrossRef][Medline]
32. Shankar, S., V. Kapatral, and A. M. Chakrabarty. 1997. Mammalian heterotrimeric G-protein-like proteins in mycobacteria: implications for cell signalling and survival in eukaryotic host cells. Mol. Microbiol. 26:607-618.[CrossRef][Medline]
33. Soengas, M. S., R. M. Alarcon, H. Yoshida, A. J. Giaccia, R. Hakem, T. W. Mak, and S. W. Lowe. 1999. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284:156-159.[Abstract/Free Full Text]
34. Sundin, G. W., S. Shankar, S. A. Chugani, B. A. Chopade, A. Kavanaugh-Black, and A. M. Chakrabarty. 1996. Nucleoside diphosphate kinase from Pseudomonas aeruginosa: characterization of the gene and its role in cellular growth and exopolysaccharide alginate synthesis. Mol. Microbiol. 20:965-979.[CrossRef][Medline]
35. Tang, H. B., E. DiMango, R. Bryan, M. Gambello, B. H. Iglewski, J. B. Goldberg, and A. Prince. 1996. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect. Immun. 64:37-43.[Abstract]
36. Thornborrow, E. C., S. Patel, A. E. Mastropietro, E. M. Schwartzfarb, and J. J. Manfredi. 2002. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene 21:990-999.[CrossRef][Medline]
37. Tiemann, F., J. Zerrahn, and W. Deppert. 1995. Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation. J. Virol. 69:6115-6121.[Abstract]
38. van de Kamp, M., M. C. Silvestrini, M. Brunori, J. Van Beeumen, F. C. Hali, and G. W. Canters. 1990. Involvement of the hydrophobic patch of azurin in the electron-transfer reactions with cytochrome C551 and nitrite reductase. Eur. J. Biochem. 194:109-118.[Medline]
39. van Pouderoyen, G., G. Cigna, G. Rolli, F. Cutruzzola, F. Malatesta, M. C. Silvestrini, M. Brunori, and G. W. Canters. 1997. Electron-transfer properties of Pseudomonas aeruginosa [Lys44, Glu64]azurin. Eur. J. Biochem. 247:322-331.[Medline]
40. Vogelstein, B., D. Lane, and A. J. Levine. 2000. Surfing the p53 network. Nature 408:307-310.[CrossRef][Medline]
41. Wolter, K. G., Y. T. Hsu, C. L. Smith, A. Nechushtan, X. G. Xi, and R. J. Youle. 1997. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1281-1292.[Abstract/Free Full Text]
42. Xie, Z.-D., C. D. Hershberger, S. Shankar, R. W. Ye, and A. M. Chakrabarty. 1996. Sigma factor-anti-sigma factor interaction in alginate synthesis: inhibition of AlgT by MucA. J. Bacteriol. 178:4990-4996.[Abstract/Free Full Text]
42. Yamada, T., M. Goto, V. Punj, O. Zaborina, M. L. Chen, K. Kimbara, D. Majumdar, E. Cunningham, T. K. Das Gupta, and A. M. Chakrabarty. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Proc. Natl. Acad. Sci. USA, in press.
43. Zaborina, O., N. Dhiman, C. M. Ling, J. Kostal, I. A. Holder, and A. M. Chakrabarty. 2000. Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis. Microbiology 146:2521-2530.[Abstract/Free Full Text]
44. Zou, H., Y. Li, X. Liu, and X. Wang. 1999. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:11549-11556.[Abstract/Free Full Text]
45. Zychlinsky, A., and P. Sansonetti. 1997. Apoptosis in bacterial pathogenesis. J. Clin. Investig. 100:493-495.[Medline]

Infection and Immunity, December 2002, p. 7054-7062, Vol. 70, No. 12
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.12.7054-7062.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, T.
Right arrow Articles by Chakrabarty, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, T.
Right arrow Articles by Chakrabarty, A. M.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals